Latest Class Action Settlement News

AMP has reached an agreement in principle to settle a long-running class action over commissions paid between 2014 and 2021, agreeing to pay $29 million without admitting liability.

The Federal Court of Australia has approved BHP’s AU$110 million settlement of the Samarco shareholder class action, marking a significant legal milestone for the mining giant.

Monash IVF Group reported solid FY25 revenue and EBITDA growth despite sector softness and clinical incidents, while announcing a leadership transition and dividend pause.

Noumi Limited reported a 9.0% increase in revenue to $162.4 million for Q1 FY26, driven by strong growth in Dairy and Nutritionals and Milklab plant-based milks, while successfully closing legacy legal matters.

AMP Limited reports a 3.6% rise in total assets under management, driven by a 61.6% jump in Platforms net cashflows and steady growth across divisions, alongside significant legal settlements.

Noumi Limited has completed its $11.56 million payment towards a $43 million class action settlement, now unconditional following Victorian Supreme Court approval. The payment was made by insurers, activating legal releases for the company.

Shine Justice Ltd reported a 4.4% rise in FY25 revenue to $204.4 million, alongside major legal settlements and leadership changes, signaling renewed growth momentum.

EML Payments reported a 9% revenue increase and 13% rise in underlying EBITDA for FY25, driven by strategic partnerships and operational transformation. The company sets a steady growth outlook for FY26 despite expected interest revenue headwinds.

EML Payments Limited reported a 9% revenue increase and 13% rise in underlying EBITDA for FY25, while advancing its EML2.0 transformation and Project Arlo technology platform. Despite a net loss impacted by a shareholder class action provision, the company’s renewed client pipeline and strategic restructuring signal a pivotal phase ahead.

Monash IVF Group reported a 5.6% rise in underlying EBITDA for FY25, navigating a declining Australian IVF market and operational challenges. The company sets a cautious FY26 NPAT guidance of $20-23 million while focusing on regaining market leadership and implementing safety reforms.

Monash IVF Group reported a 6.7% revenue increase to $271.9 million in FY25 but saw an 8.1% decline in underlying net profit after tax to $27.4 million, impacted by market softness and operational incidents. The company outlines cautious FY26 guidance amid ongoing sector headwinds.

Noumi Limited reported a nearly flat Q4 FY25 revenue with mixed segment performances and flagged a net loss for the year amid legacy legal expenses. The company highlights growth in its Milklab brand and export sales while managing significant convertible note obligations.